21st European Congress on Alternatives to Animal Testing, September 23-26 2018, University of Linz, Austria

Topics / tentative sessions

(as of 21 December 2017)

Advanced technologies: systems biology, -omics technologies, stem cells


3D models & multi-organ-chips (MOC), human-organ-chips (HOC)


International progress in 3Rs research - Global cooperation on implementing the 3Rs


Replacement – new approaches


REACH I – the most frequently used alternatives: "read accross, WoE (Weight of Evidence) & QSAR"


REACH II– meeting the 2018 deadline


Predictive toxicology & risk assessment  


Advanced safety testing of cosmetics and consumer products


Specific toxicological endpoints: oral & repeated-dose toxicity, inhalation toxicity, sensitization, reprotox (mEST & hEST), carcinogenesis, nanotoxicology


Efficacy and safety testing of drugs and biopharmaceutics including vaccines, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein and living cells used in cell therapy


3Rs in medical devices testing


Initiative for implementing serum free culture media


Disease models using human cells, tissues and organs


Biological Barriers


Advanced GMO models – CRISPR/cas in vivo & in vitro


Ethical and legal issues & Dir 63/2010/EU update


Refinement & welfare, culture of care, best practice approaches, avoidance of severe suffering


3Rs in education and academia


"Young Scientists" session


Free communications


Deadlines for your submission of abstracts:


- Submission of oral presentations: 31 May 2018
- Submission of posters: 31 May 2018
- Delivery of powerpoint presentations: 14 September 2018

(Please note: The online submission system will be online on 25 January 2018)

Please stay in touchcongress2018@eusaat-congress.eu or subscribe to the newsletter!

If you've any questions, please contact the congress office!